Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas

Abstract Background The programmed death-1/programmed death-ligand-1 (PD-1/PD-L1) immune regulatory axis has emerged as a promising new target for cancer therapeutics, with lasting responses seen in the treatment of metastatic renal and lung carcinomas, as well as melanomas. As tumor surface express...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Opal L. Reddy (Auteur), Peter I. Shintaku (Auteur), Neda A. Moatamed (Auteur)
Format: Livre
Publié: BMC, 2017-06-01T00:00:00Z.
Sujets:
Accès en ligne:Connect to this object online.
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

Connect to this object online.

3rd Floor Main Library

Informations d'exemplaires de 3rd Floor Main Library
Cote: A1234.567
Exemplaire 1 Disponible